Phase II Study of Reduced Intensity Sibling Allogeneic Transplantation for Relapsed, Chemosensitive, PET Positive Hodgkin Lymphoma. Key words: Reduced intensity conditioning, Transplantation, Hodgki...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-004955-31

Phase II Study of Reduced Intensity Sibling Allogeneic Transplantation for Relapsed, Chemosensitive, PET Positive Hodgkin Lymphoma. Key words: Reduced intensity conditioning, Transplantation, Hodgkin lymphoma

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To assess progression free survival following reduced intensity allogeneic transplantation in a relatively poor prognostic group of Hodgkin lymphoma patients, and allow comparison with historically expected results for autografting. The primary end point is progression free survival.


Critère d'inclusion

  • Relapsed Hodgkin Lymphoma

Liens